FDA Approves PREZISTA®/ritonavir Once-Daily Dosing For HIV-1 Treatment-Experienced Adults With No Darunavir Resistance-Associated Mutations
Links shared publicly online about this topic.
- 653total visits
FDA Approves PREZISTA®/ritonavir Once-Daily Dosing For HIV-1 Treatment-Experienced Adults With No Darunavir Resistance-Associated Mutations
View full resource at medicalnewstoday.com
Tags: HIV Medication, Drug, Biotech, FDA, Prezista
Most Recently Shared on December 15, 2010 at 10:05 pm By:
FDA Approves PREZISTA®/ritonavir Once-Daily Dosing For HIV-1 Treatment-Experienced Adults With No Darunavir Resist... http://mnt.to/3P6k
Also Shared By:
Americans stuck on Botox for 10 years now – USATODAY.com
usatoday.com — “The toxin's popularity has skyrocketed, along with its medical uses, since FDA approval a decade ago this week.” View full resource at usatoday.com
Most Recently Shared on April 12, 2012 at 11:56 am By:
Dr Emily Altman Dermatologist, Physician, Active Health Library, and Doctor
Botox' 10th Anniversary - USA Today story... http://t.co/UF56v1rk
FDA Approves Alzheimer's Test Developed by Eli Lilly - WSJ.com
online.wsj.com — “The FDA approved an Eli Lilly test that can help detect Alzheimer's—a potential boon to treatment and developing drugs against the disease.” View full resource at online.wsj.com
Most Recently Shared on April 8, 2012 at 11:34 pm By:
Tom Heston, MD Family Medicine Doctor, Physician, and Doctor
Alzheimer Diagnosis Possible With Scan - Wall Street Journal http://t.co/gle8vhJV #health
Weight loss pill Qnexa wins panel vote and awaits approval
news-medical.net — “The drug was rejected in a 10-6 vote the first time it came before a Food and Drug Administration (FDA) advisory panel, in 2010, due to safety concerns. However when the medication returned for another review in February, the advisory committee gave it near-unanimous approval (20-2). Because the FDA often follows the advisory panel's advice, Qnexa is likely to get FDA approval, probably by mid-April.” View full resource at news-medical.net
Most Recently Shared on April 5, 2012 at 11:08 pm By:
Diet News: Weight loss pill Qnexa wins panel vote and awaits approval: The drug was rejected in a 10-6 vote the ... http://t.co/rGbONdEq
Pharmacy OneSource
rph.com — “The combined company of Pharmacy OneSource and Healthprolink enables swift and safe healthcare through innovative, web-based software solutions.” View full resource at rph.com
Most Recently Shared on April 5, 2012 at 5:14 pm By:
What did the FDA approve this week? Read to find out: http://t.co/FlA0waFm
preview
emailactivity.ecn5.com — “preview” View full resource at emailactivity.ecn5.com
Most Recently Shared on April 5, 2012 at 12:30 pm By:
New diet drug Qnexa awaits FDA approval amid safety questions – USATODAY.com
usatoday.com — “Some experts say it could potentially help dieters lose about 10% of their weight, but with its former FDA rejection, how safe is it?” View full resource at usatoday.com
Most Recently Shared on April 4, 2012 at 10:45 pm By:
Diet drug Qnexa awaits FDA approval amid safety questions http://t.co/YjlUT7Bn
preview
emailactivity.ecn5.com — “preview” View full resource at emailactivity.ecn5.com
Most Recently Shared on April 3, 2012 at 6:14 pm By:
Is FDA's approval process good enough? - CBS News Video
cbsnews.com — “CBS News video: Is FDA's approval process good enough? - Dr. Robert Hauser had confidence in the cardiac defibrillator he implanted in teenager Joshua Oukrop. But when the device failed and Josh died, Dr. Hauser began a quest to discover why. Jim Axelrod reports on what he found.” View full resource at cbsnews.com
Most Recently Shared on April 1, 2012 at 8:34 pm By:
Is FDA's approval process good enough? - CBS News Video http://t.co/UiHOMdxq
Text of H.R.3847 as Introduced in House: SOUND Devices Act of 2012 - U.S. Congress - OpenCongress
opencongress.org — “Full bill text of H.R.3847 SOUND Devices Act of 2012 on OpenCongress.org” View full resource at opencongress.org
Most Recently Shared on March 30, 2012 at 5:28 pm By:
Sen draft bill won't let FDA remove recalled devices 4rm predicate list--pred nullification. SOUND Act does http://t.co/ANUW11Fe #sppchat
Consumer Reports Warns of Lax Testing for Medical Devices - ABC News
abcnews.go.com — “Consumer Reports advises patients to do their homework before having medical devices implanted in their bodies. Companies that sell defibrillators, stents or other such products can get approval from the Food and Drug Administration without their undergoing rigorous testing, Consumer Reports warned in a new report. The FDA collects information on medical device malfunctions that lead to death. Data highlighted by Consumer Reports show 686 deaths from 2009 to last year connected to automate” View full resource at abcnews.go.com
Most Recently Shared on March 29, 2012 at 7:39 pm By:
HealthIT Policy Health News and Health IT
Consumer Reports Warns of Lax Testing for Medical Devices: Consumer Reports advises patients to do their homewor... http://t.co/z5sM68RZ
Pharmacy OneSource
rph.com — “The combined company of Pharmacy OneSource and Healthprolink enables swift and safe healthcare through innovative, web-based software solutions.” View full resource at rph.com
Most Recently Shared on March 29, 2012 at 4:59 pm By:
See what the FDA approved this week: http://t.co/EvVxfVTP
2 medical experts criticize FDA approval of high-dose Aricept - Related Stories - Hospice and Palliative Medicine SmartBrief
smartbrief.com — “The FDA's authorization of a higher dose of Aricept, an Alzheimer's disease drug marketed by Eisai and Pfizer, went against reviewers' advice and regulatory standard, Steven Woloshin and Lisa Schwartz of Dartmouth College wrote in BMJ. They said 23-milligram Aricept did not significantly improve co…” View full resource at smartbrief.com
Most Recently Shared on March 28, 2012 at 9:06 pm By:
Lionel Lim Physician, Doctor, Internist, and Geriatrician
2 medical experts criticize FDA approval of high-dose Aricept http://t.co/2ThotsPL
Amgen Loses Monopoly on Drug for Dialysis Patients - NYTimes.com
nytimes.com — “The Food and Drug Administration approved a new anemia drug called Omontys for dialysis patients, which will end Amgen’s 24-year monopoly led by its Epogen drug.” View full resource at nytimes.com
Most Recently Shared on March 28, 2012 at 6:19 pm By:
Daniel Kraft Health Executive, Physician, Doctor, Pediatrician, and Internist
NYTimes: F.D.A. Approves New Anemia Drug http://t.co/WJKYbgWZ
Amgen Loses Monopoly on Drug for Dialysis Patients - NYTimes.com
nytimes.com — “The Food and Drug Administration approved a new anemia drug called Omontys for dialysis patients, which will end Amgen’s 24-year monopoly led by its Epogen drug.” View full resource at nytimes.com
Most Recently Shared on March 28, 2012 at 1:16 am By:
FDA Approves New Anemia Drug http://t.co/Auh0ppSW
Affymax and Takeda Announce FDA Approval of Omontys (peginesatide) Injection for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Adult Patients on Dialysis
drugs.com — “Omontys (peginesatide) is used to treat anemia due to Chronic Kidney Disease. Includes Omontys side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on March 27, 2012 at 11:41 pm By:
FDA Approves Omontys (peginesatide) for the Treatment of Anemia Due to Chronic Kidney Disease - http://t.co/rluIf9fp
Advertisement
MNT HIV/Aids
@mnt_hivaids
FDA Approves PREZISTA®/ritonavir Once-Daily Dosing For HIV-1 Treatment-Experienced Adults With No Darunavir Resist... http://mnt.to/3P6k
1 year ago...